{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:24:47Z","timestamp":1787012687210,"version":"build-2736575974"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol Surg Rep"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sinonasal pediatric rhabdomyosarcoma is a rare cancer with a prognosis dependent on stage\/grade, histology, and molecular characteristics. Radiation therapy is considered first-line therapy in conjunction with chemotherapy, determined based on the disease risk group. Surgery is generally recommended when margin-free resections are possible. Here we present a unique case report of a patient with recurrent rhabdomyosarcoma and an overview of the salient literature pertaining to the management of this case.<\/jats:p>","DOI":"10.1055\/a-2907-5254","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:29:25Z","timestamp":1786404565000},"page":"e141-e143","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Rhabdomyosarcoma in the Head and Neck: An Overview"],"prefix":"10.1055","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-7855","authenticated-orcid":false,"given":"Michael","family":"Sabbaj","sequence":"additional","affiliation":[{"name":"Larner College of Medicine, The University of Vermont, Vermont, United States","place":["Burlington"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Winsnes","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Oregon, United States","place":["Portland"],"department":["Division of Hematology and Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Geltzeiler","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Oregon, United States","place":["Portland"],"department":["Department of Otolaryngology-Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pbc.24435","article-title":"Children\u2019s oncology group\u2019s 2013 blueprint for research: soft tissue sarcomas","volume":"60","author":"D S Hawkins","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"ref2","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2600 patients","volume":"27","author":"I Sultan","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref3","volume-title":"WHO Classification of Head and Neck Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00428-019-02676-9","article-title":"The current landscape of rhabdomyosarcomas: an update","volume":"476","author":"J Leiner","year":"2020","journal-title":"Virchows Arch"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/alr.23262","article-title":"International consensus statement on allergy and rhinology: sinonasal tumors","volume":"14","author":"E C Kuan","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpo.1259","article-title":"Treatment of children and adolescents with localized parameningeal sarcoma: experience of the intergroup rhabdomyosarcoma study group protocols IRS-II through -IV, 1978-1997","volume":"38","author":"R B Raney","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"e29644","DOI":"10.1002\/pbc.29644","article-title":"Clinical group and modified TNM stage for rhabdomyosarcoma: a review from the children\u2019s oncology group","volume":"69","author":"J N Crane","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/djaa204","article-title":"Germline cancer predisposition variants in pediatric rhabdomyosarcoma: a report from the children\u2019s oncology group","volume":"113","author":"H Li","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/annonc\/mdt426","article-title":"Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from north American and European cooperative groups","volume":"25","author":"J H Merks","year":"2014","journal-title":"Ann Oncol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L","article-title":"Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification\u2014an intergroup rhabdomyosarcoma study","volume":"76","author":"W A Newton Jr","year":"1995","journal-title":"Cancer"},{"issue":"09","key":"ref11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/pbc.24532","article-title":"PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children\u2019s oncology group report","volume":"60","author":"S X Skapek","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.22.02093","article-title":"Nonmetastatic rhabdomyosarcoma in children and adolescents: overall results of the European Pediatric soft tissue sarcoma study group RMS2005 study","volume":"41","author":"G Bisogno","year":"2023","journal-title":"J Clin Oncol"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers12071758","article-title":"Recent advances and challenges in the treatment of rhabdomyosarcoma","volume":"12","author":"S Miwa","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"W M Crist","year":"2001","journal-title":"J Clin Oncol"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(18)30337-1","article-title":"European Paediatric Soft Tissue Sarcoma Study Group. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"19","author":"G Bisogno","year":"2018","journal-title":"Lancet Oncol"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12887-020-02165-y","article-title":"Radiation therapy is an important factor to improve survival in pediatric patients with head and neck rhabdomyosarcoma by enhancing local control: a historical cohort study from a single center","volume":"20","author":"Y Wen","year":"2020","journal-title":"BMC Pediatr"},{"issue":"31","key":"ref17","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1200\/JCO.22.02673","article-title":"Which patients with rhabdomyosarcoma need radiotherapy? Analysis of the radiotherapy strategies of the CWS-96 and CWS-2002P studies and SoTiSaR registry","volume":"41","author":"E Koscielniak","year":"2023","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cncr.33275","article-title":"Benefit of delayed primary excision in rhabdomyosarcoma: a report from the children\u2019s oncology group","volume":"127","author":"T B Lautz","year":"2021","journal-title":"Cancer"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/cam4.855","article-title":"Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma","volume":"5","author":"K Kobayashi","year":"2016","journal-title":"Cancer Med"}],"container-title":["Journal of Neurological Surgery Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2907-5254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:32:34Z","timestamp":1787009554000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2907-5254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2907-5254","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2193-6358","2193-6366"],"issn-type":[{"value":"2193-6358","type":"print"},{"value":"2193-6366","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,10]]},"published":{"date-parts":[[2026,7]]}}}